Gyre Therapeutics Announces Publication In Journal Of Gastroenterology And Hepatology; Manuscript Highlights Potential Of Hydronidone (F351) As Therapy For Liver Fibrosis Through Apoptotic Pathway In Hepatic Stellate Cells
Gyre Therapeutics Announces Publication In Journal Of Gastroenterology And Hepatology; Manuscript Highlights Potential Of Hydronidone (F351) As Therapy For Liver Fibrosis Through Apoptotic Pathway In Hepatic Stellate Cells
Gyre Therapeutics宣佈在《消化和肝病學雜誌》上發表論文；手稿突出了Hydronidone（F351）通過肝星狀細胞凋亡途徑治療肝纖維化的潛力。
Gyre Therapeutics Announces Publication In Journal Of Gastroenterology And Hepatology; Manuscript Highlights Potential Of Hydronidone (F351) As Therapy For Liver Fibrosis Through Apoptotic Pathway In Hepatic Stellate Cells
Gyre Therapeutics宣佈在《消化和肝病學雜誌》上發表論文；手稿突出了Hydronidone（F351）通過肝星狀細胞凋亡途徑治療肝纖維化的潛力。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。